Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial.

Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial. Cancer Prev Res (Phila). 2013 May; 6(5):410-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.